Results 191 to 200 of about 3,082,206 (396)

Partial nephrectomy for presumed renal cell carcinoma: Incidence, predictors, and perioperative outcomes of benign lesions [PDF]

open access: yes, 2017
Bauman, Tyler M   +5 more
core   +2 more sources

Small Cell Carcinoma of the Hypopharynx [PDF]

open access: diamond, 2018
Ruixiang Sun   +2 more
openalex   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye   +11 more
wiley   +1 more source

A case of cervical cancer with a combination of adenocarcinoma and small cell carcinoma components

open access: diamond, 2017
Yusuke TAKANEZAWA   +4 more
openalex   +1 more source

Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study [PDF]

open access: hybrid, 2020
Erkan Topkan   +11 more
openalex   +1 more source

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann   +17 more
wiley   +1 more source

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

open access: yesClinical Cancer Research, 2015
H. Tsai   +17 more
semanticscholar   +1 more source

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.

open access: yesCancer Research, 2016
E. Wallace   +21 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy